COVID-19 vaccine is one of four advanced mRNA-based vaccines, which is a nucleoside-modified mRNA (modRNA) vaccine encoding an optimized full-length version of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein. It is designed to induce immunity against SARS-CoV-2, the virus responsible for causing COVID-19. The modRNA is formulated in lipid nanoparticles for administration via intramuscular injection in two doses, three weeks apart.
The scientific team in Creative BioMart Therapeutic Proteins is always ready to learn details of various projects and collaborate with customers to supply high-quality and cost-efficient products and services.